phenylacetate/stroke

链接已保存到剪贴板

文章临床试验专利权

选择排序类型

3 结果

Relation of Paraoxonase1, Arylesterase and Lipid Profile in Ischemic Stroke Patients.

只有注册用户可以翻译文章

登陆注册

BACKGROUND Paraoxonase 1 (PON1) is an enzyme associated with High density lipoprotein (HDL) in blood and it is considered to have antioxidant and antiatherogenic properties. PON1 plays an important role in protecting HDL and especially low density lipoprotein (LDL) from oxidative modification by

R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke.

只有注册用户可以翻译文章

登陆注册

The polymorphic gene of serum paraoxonase (PON1) and its activity involved in atherosclerosis. The purpose of the study was to analyze PON1 192 Q/R polymorphism and the enzyme activities in ischemic stroke. The polymorphism as the most common polymorphism in PON1 gene coding sequence is associated

Conventional protein kinase Cβ-mediated phosphorylation inhibits collapsin response-mediated protein 2 proteolysis and alleviates ischemic injury in cultured cortical neurons and ischemic stroke-induced mice.

只有注册用户可以翻译文章

登陆注册

We previously reported that conventional protein kinase C (cPKC)β participated in hypoxic preconditioning-induced neuroprotection against cerebral ischemic injury, and collapsin response-mediated protein 2 (CRMP2) was identified as a cPKCβ interacting protein. In this study, we explored the

加入我们的脸书专页

Herbal & Natural Medicine

科学支持的最完整的草药数据库

支持55种语言
科学支持的草药疗法
通过图像识别草药
交互式GPS地图-在位置标记草药（即将推出）
阅读与您的搜索相关的科学出版物
通过药效搜索药草
组织您的兴趣并及时了解新闻研究，临床试验和专利

输入症状或疾病，并阅读可能有用的草药，输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究